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1. INTRODUCTION {#ajim23106-sec-0050}
===============

Asbestos, a generic term for naturally occurring fibrous mineral silicates, is recognized as a carcinogen by the general medical and scientific communities. In 1960, Wagner et al[^1^](#ajim23106-bib-0001){ref-type="ref"} reported a large series of malignant mesotheliomas in individuals who had been exposed to asbestos from a South African asbestos mine. It has been demonstrated that all types of asbestos and even brief and low‐dose exposures are capable of causing malignant mesothelioma.[^2^](#ajim23106-bib-0002){ref-type="ref"}, [^3^](#ajim23106-bib-0003){ref-type="ref"}, [^4^](#ajim23106-bib-0004){ref-type="ref"} In the 1970s, several types of cosmetic talcum powder products were demonstrated to contain asbestos.[^5^](#ajim23106-bib-0005){ref-type="ref"}, [^6^](#ajim23106-bib-0006){ref-type="ref"}, [^7^](#ajim23106-bib-0007){ref-type="ref"} Asbestos fibers in commercial talcum powder have also been shown to become airborne upon application, and repeated exposures to cosmetic talc were implicated as a cause of mesothelioma by Gordon et al.[^8^](#ajim23106-bib-0008){ref-type="ref"} Recently, Moline et al,[^9^](#ajim23106-bib-0009){ref-type="ref"} reported a series of 33 subjects with malignant mesothelioma, whose only known exposure to asbestos was cosmetic talc. We present 75 additional subjects, with malignant mesothelioma, whose only known exposure to asbestos was cosmetic talc.

2. METHODS {#ajim23106-sec-0060}
==========

One hundred forty subjects with documented exposures to cosmetic talc were initially reviewed. Exposures were identified through sworn deposition testimonies and answers to sworn interrogatories provided from subjects, parents, and spouses. Sixty‐five subjects were excluded due to recalled occupational or paraoccupational exposures to other sources of asbestos. Seventy‐five subjects, whose only known exposure to asbestos was via cosmetic talc, were included for further examination. The asbestos content of talcum products and airborne asbestos concentrations during simulations of the usage of these products was determined in previously published studies.[^10^](#ajim23106-bib-0010){ref-type="ref"}, [^11^](#ajim23106-bib-0011){ref-type="ref"}

Tissues from biopsies and/or debulking procedures were examined and the diagnosis of malignant mesothelioma was confirmed by a board‐certified pathologist (JCM, TSE, RLK). Immunohistochemical staining results for BAP‐1 were available in a few cases but was not routinely performed as a part of this study.

No efforts were made to reconstruct levels of exposure but all subjects had been repeatedly exposed over many years. Eleven cases were examined for the presence of asbestiform fibers (aspect ratio, ≥3:1) in sampled tissues. Nine subjects were examined both by analytical transmission electron microscopy (ATEM) and microprobe analysis (MA) (see Table [2](#ajim23106-tbl-0002){ref-type="table"}), whereas two were examined by scanning electron microscopy (SEM) and MA (results not shown).

3. RESULTS {#ajim23106-sec-0070}
==========

The pertinent data from the 75 subjects is shown in Table [1](#ajim23106-tbl-0001){ref-type="table"}. All had pathologically confirmed malignant mesothelioma. Sixty‐four subjects were females, 11 were males. The mean age at diagnosis was 61 ± 17 years, with a range of 14 to 94 years. The mean exposure duration was 33 ± 16 years with a range of exposure from 6 to 65 years. The mean latency from time of first exposure to diagnosis was 50 ± 13 years with a range of 14 to 72 years. A total of 4 of the 75 cases (5%) occurred in barbers/cosmetologists, or in a family member who swept the barber shop. Twelve (16%) were 45 years old or younger (10 females, 2 males) at the time of diagnosis. Forty‐eight mesotheliomas were pleural (40 females; 8 in males); 23 peritoneal (21 females; 2 men). Two presented with both pleural and peritoneal disease. There was one pericardial (woman), and one testicular mesothelioma. The majority, 51 (68%) were of epithelioid subtype, 13 biphasic (17%), 8 sarcomatoid (11%), 2 lymphohistiocytoid (3%), and 1 poorly differentiated (1%). Treatment, therapeutic outcomes, and survival were not determined in this study.

###### 

Seventy‐five mesothelioma cases exposed to talcum powder

  Case                                                Sex   Year of diagnosis   Age at diagnosis   Mesothelioma site      Histology               Estimated years of use   Estimated years of latency
  --------------------------------------------------- ----- ------------------- ------------------ ---------------------- ----------------------- ------------------------ ----------------------------
  1                                                   F     2017                72                 Pleural                Epithelioid             20                       57
  2                                                   F     2014                51                 Peritoneal             Epithelioid             30                       50
  3                                                   F     2017                50                 Pleural                Lymphohistiocytoid      41                       50
  4                                                   F     2017                57                 Peritoneal             Epithelioid             30                       52
  5                                                   F     2015                65                 Pleural                Epithelioid             39                       62
  6                                                   F     2017                39                 Peritoneal             Sarcomatoid             15                       39
  7                                                   F     2016                29                 Pericardial            Epithelioid             29                       29
  8                                                   F     2017                94                 Pleural                Epithelioid             60                       72
  9                                                   F     2015                80                 Pleural                Epithelioid             19                       59
  10                                                  F     2016                72                 Pleural                Sarcomatoid             43                       59
  11                                                  F     2013                66                 Peritoneal             Epithelioid             20                       52
  12                                                  F     2011                48                 Pleural                Lymphohistiocytoid      13                       21
  13                                                  F     2010                51                 Peritoneal             Epithelioid             15                       20
  14                                                  F     2018                55                 Peritoneal             Epithelioid             40                       42
  15                                                  M     2017                81                 Pleural                Sarcomatoid             60                       60
  16                                                  F     2018                56                 Pleural                Epithelioid             48                       52
  17                                                  F     2017                32                 Peritoneal             Epithelioid             25                       32
  18                                                  F     2017                89                 Pleural                Sarcomatoid             40                       42
  19                                                  F     2019                73                 Peritoneal             Epithelioid             47                       56
  20                                                  M     2016                70                 Pleural                Poorly differentiated   50                       55
  21                                                  F     2015                66                 Pleural                Epithelioid             40                       43
  22                                                  F     2016                45                 Pleural                Epithelioid             10                       45
  23                                                  F     2018                45                 Peritoneal             Epithelioid             39                       45
  24                                                  M     2015                67                 Pleural + peritoneal   Epithelioid             35                       60
  25                                                  M     2017                78                 Peritoneal             Biphasic                50                       62
  26                                                  F     2018                57                 Peritoneal             Biphasic                25                       57
  27                                                  F     2013                14                 Peritoneal             Epithelioid             12                       14
  28                                                  F     2016                67                 Peritoneal             Epithelioid             15                       59
  29                                                  F     2018                73                 Pleural                Epithelioid             30                       65
  30                                                  F     2018                76                 Pleural                Biphasic                60                       55
  31                                                  M     2017                39                 Testis                 Epithelioid             7                        39
  32                                                  F     2018                57                 Pleural                Sarcomatoid             57                       57
  33                                                  F     2016                68                 Pleural                Epithelioid             38                       64
  34                                                  F     2017                80                 Pleural                Epithelioid             50                       60
  35                                                  F     2016                63                 Pleural                Epithelioid             15                       54
  36                                                  F     2017                58                 Pleural                Biphasic                20                       58
  37                                                  F     2017                71                 Pleural                Biphasic                60                       71
  38                                                  F     2014                70                 Pleural                Epithelioid             41                       39
  39                                                  F     2016                26                 Peritoneal             Epithelioid             20                       26
  40                                                  F     2016                35                 Pleural                Epithelioid             35                       35
  41                                                  F     2017                72                 Pleural                Sarcomatoid             23                       60
  42                                                  F     2016                68                 Peritoneal             Epithelioid             65                       68
  43                                                  F     2018                77                 Pleural                Biphasic                30                       55
  44                                                  M     2015                58                 Plural                 Biphasic                6                        49
  45                                                  F     2017                72                 Peritoneal             Biphasic                30                       42
  46                                                  F     2017                59                 Pleural + peritoneal   Epithelioid             15                       44
  47                                                  F     2016                80                 Pleural                Biphasic                16                       52
  48                                                  M     2019                71                 Pleural                Epithelioid             40                       57
  49                                                  F     2017                72                 Pleural                Biphasic                58                       58
  50                                                  F     2017                43                 Peritoneal             Epithelioid             43                       43
  51                                                  F     2017                75                 Peritoneal             Sarcomatoid             55                       59
  52                                                  F     2015                30                 Pleural                Epithelioid             20                       20
  53                                                  F     2017                79                 Pleural                Biphasic                65                       61
  54                                                  F     2017                66                 Peritoneal             Epithelioid             20                       60
  55                                                  F     2015                64                 Peritoneal             Epithelioid             40                       40
  56                                                  F     2017                24                 Pleural                Epithelioid             12                       24
  57                                                  M     2017                72                 Pleural                Epithelioid             30                       56
  58                                                  M     2017                74                 Peritoneal             Epithelioid             30                       52
  59                                                  M     2015                30                 Pleural                Epithelioid             20                       30
  60                                                  F     2016                81                 Pleural                Sarcomatoid             52                       52
  61                                                  F     2017                58                 Pleural                Epithelioid             58                       58
  62                                                  F     2016                75                 Pleural                Epithelioid             8                        47
  63                                                  F     2011                88                 Pleural                Epithelioid             21                       71
  64                                                  F     2016                73                 Peritoneal             Biphasic                41                       60
  65[^a^](#ajim23106-tbl1-note-0001){ref-type="fn"}   M     2017                64                 Pleural                Epithelioid             18                       40
  66[^a^](#ajim23106-tbl1-note-0001){ref-type="fn"}   F     2014                69                 Pleural                Epithelioid             16                       60
  67[^a^](#ajim23106-tbl1-note-0001){ref-type="fn"}   F     2014                44                 Peritoneal             Epithelioid             30                       39
  68[^a^](#ajim23106-tbl1-note-0001){ref-type="fn"}   F     2016                68                 Pleural                Epithelioid             53                       52
  69[^a^](#ajim23106-tbl1-note-0001){ref-type="fn"}   F     2016                72                 Pleural                Epithelioid             40                       51
  70[^a^](#ajim23106-tbl1-note-0001){ref-type="fn"}   F     2016                67                 Pleural                Epithelioid             37                       53
  71[^a^](#ajim23106-tbl1-note-0001){ref-type="fn"}   F     2017                58                 Pleural                Epithelioid             41                       46
  72[^a^](#ajim23106-tbl1-note-0001){ref-type="fn"}   M     2016                44                 Pleural                Epithelioid             43                       44
  73[^a^](#ajim23106-tbl1-note-0001){ref-type="fn"}   F     2017                51                 Pleural                Epithelioid             28                       49
  74[^a^](#ajim23106-tbl1-note-0001){ref-type="fn"}   F     2015                47                 Pleural                Epithelioid             15                       40
  75[^a^](#ajim23106-tbl1-note-0001){ref-type="fn"}   F     2014                62                 Pleural                Biphasic                14                       53

Tissue analysis performed.

John Wiley & Sons, Ltd.

For the 11 subjects whose tissues were examined by ATEM and ASEM, the analysis showed the presence of tremolite and/or anthophyllite in all 11 subjects (Table [2](#ajim23106-tbl-0002){ref-type="table"}).

###### 

Fiber detection in tissue digestion from nine cases of malignant mesothelioma

                                                                               Concentration (fibers per gram of wet tissue)   Limit of detection (fibers per gram of wet tissue)   Tissue digest weight (g)
  ---- ------------ ------------------------------------ --------------------- ----------------------------------------------- ---------------------------------------------------- --------------------------
  65   Pleural      Anthophyllite, tremolite             Lung, lymph node      8625                                            4313                                                 0.08, 0.34
  66   Pleural      Anthophyllite                        Lung, lymph node      15 333, 23 000                                  7667, 1150                                           0.06, 0.06
  67   Peritoneal   Anthophyllite, tremolite             Omentum, lymph node   1917, 1725                                      639, 1725                                            0.54, 0.20
  68   Pleural      Anthophyllite, tremolite             Lymph node            3044                                            1015                                                 0.82, 0.34
  70   Pleural      Anthophyllite, amosite, chrysotile   Lymph node            17 250                                          3450                                                 1.06
  71   Pleural      Anthophyllite, tremolite             Lung, lymph node      4313, 857, 3451                                 2156, 857, 575                                       0.16
  72   Pleural      Anthophyllite, tremolite             Lymph node            17 250                                          3450                                                 0.02
  74   Pleural      Anthophyllite, tremolite             Lung                  2300                                            460                                                  2
  75   Pleural      Anthophyllite                        Lung, ovary           3450, 2070                                      1150, 2070                                           0.6, 0.2

*Note*: All cases shown were examined by analytical transmission electron microscopy and structures analyzed by microprobe analysis.

John Wiley & Sons, Ltd.

4. DISCUSSION {#ajim23106-sec-0080}
=============

The 75 individuals with malignant mesothelioma caused by asbestos in cosmetic talc is currently the largest series reported to date. Recently, Moline et al reported 33 cases of malignant mesothelioma attributed to exposures to cosmetic talc. Like Moline\'s work, most of mesotheliomas in the present series occurred in women. Several mesotheliomas occurred specifically in hairdressers/barbers. Similarly, the asbestos fiber types found by ATEM in the tissues examined were comparable to those found in laboratory testing for cosmetic talc.[^10^](#ajim23106-bib-0010){ref-type="ref"}, [^11^](#ajim23106-bib-0011){ref-type="ref"}, [^12^](#ajim23106-bib-0012){ref-type="ref"}

Mesothelioma is recognized as a "signal tumor" of asbestos exposure, that is, if a patient has mesothelioma, it should signal an inquiry into potential asbestos exposure. The presence of asbestos in talc deposits has been recognized since the late 1940s.[^13^](#ajim23106-bib-0013){ref-type="ref"}, [^14^](#ajim23106-bib-0014){ref-type="ref"} Since the 1960s, laboratory testing has identified asbestos in samples of cosmetic talc.[^15^](#ajim23106-bib-0015){ref-type="ref"}, [^16^](#ajim23106-bib-0016){ref-type="ref"} Studies have confirmed that the most common types of asbestos present in cosmetic talc are tremolite, anthophyllite, and chrysotile. Industrial asbestos products used in the United States generally contained chrysotile, amosite, and/or crocidolite,[^17^](#ajim23106-bib-0017){ref-type="ref"} and anthophyllite and tremolite were rarely present.[^18^](#ajim23106-bib-0018){ref-type="ref"}

While the latency between exposure and diagnosis in the present study is similar to the average latency for the development of mesothelioma (50 years) reported in surveillance epidemiology and end results program (SEER) data,[^19^](#ajim23106-bib-0019){ref-type="ref"} the average age at diagnosis in this report (61 years) is 11 years younger than that in the SEER data (72 years). In addition, fewer than 3% of mesotheliomas in the SEER data occurred in individuals less than 45 years of age, whereas 16% of mesotheliomas of the present study occurred in individuals less than 45 years of age, and 83% of these cases were in women.[^20^](#ajim23106-bib-0020){ref-type="ref"}

The present report of 75 cases, together with the 35 cases previously reported[^8^](#ajim23106-bib-0008){ref-type="ref"}, [^9^](#ajim23106-bib-0009){ref-type="ref"} currently brings the number of individuals with confirmed diagnoses of malignant mesothelioma following repeated exposure to cosmetic talcum powder to more than 100. The presence of anthophyllite and tremolite in the fiber analysis of tissues obtained from the 11 subjects in this series, is consistent with a source in cosmetic talc.

Unlike industrial or occupational exposure to asbestos, where materials have been regulated, exposure to asbestos in cosmetic talc has not been widely reported or recognized within the medical community or to the public. Cosmetic talc products are most frequently used by women in the United States, and while the incidence of mesothelioma in women is less than in men, the majority have previously been reported as "idiopathic," indicating no recognized source of asbestos exposure. The present study supports the contention that asbestos exposure through the use of cosmetic talc accounts may account for an uncertain percentage of these cases.

The present study has several limitations. It is both retrospective and uncontrolled, and the cases were submitted in medico‐legal consultation, all of which potentially introduce bias. However, detailed deposition testimonies provide a level of detail concerning product exposure---including dates of exposure, duration, and frequency---that is rarely obtained in routine medical exposure histories, and which allowed for corroborating witness testimony in some cases. The strengths of the current series include its size, as malignant mesothelioma is a rare disease (1‐2 cases per 100 000), and its novelty, as exposures to cosmetic talc are rarely considered by most medical practitioners when they are eliciting an exposure history to asbestos.

The findings of the present and other recent studies suggest that cosmetic talc may be a cause of malignant mesothelioma. Large‐scale controlled studies will be required to assess the prospective risk of developing mesothelioma following repeated exposures to talc. Although cosmetic talcs are not currently regulated by the Food and Drug Administration, the poor prognosis of malignant mesothelioma may warrant regulation or the withdrawal of cosmetic talcs from the market, as nontoxic alternatives such as corn starch are presently available.
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